You're reading the free version. Trader adds the live tape and alerts.
Start tracking
UTHR Sale Disclosure
Rothblatt Martine A · SEC Form 4 · Filed Jun 15, 2026
Sale
Calculated transaction value
$215.91K
Rothblatt Martine A Chairperson & CEO
UTHR
Transaction date
Jun 12, 2026
Public filing date
Jun 15, 2026
Filing lag
Filed 3 days later
UTHR daily price context
Close on/before transaction
$545.96
Jun 12, 2026
First close after public filing
$548.27
Jun 16, 2026
30-day return after filing
-3.01%
Through Jul 15, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 401 shares @ $538.43
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001106578-26-000078
Filing cohort
Transactions in this filing
Showing 11 of 11
Trades
11
Issuers
1
Estimated value
$6.53M
Buys / sales
0 / 9
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| United Therapeutics Corp UTHR | Exercise | Jun 12, 2026 | $1.39M |
| United Therapeutics Corp UTHR | Sale | Jun 12, 2026 | $214.42K |
| United Therapeutics Corp UTHR | Sale | Jun 12, 2026 | $288.49K |
| United Therapeutics Corp UTHR | Sale | Jun 12, 2026 | $1.7M |
| United Therapeutics Corp UTHR | Sale | Jun 12, 2026 | $904.39K |
| United Therapeutics Corp UTHR Current | Sale | Jun 12, 2026 | $215.91K |
| United Therapeutics Corp UTHR | Sale | Jun 12, 2026 | $974.69K |
| United Therapeutics Corp UTHR | Sale | Jun 12, 2026 | $130.33K |
| United Therapeutics Corp UTHR | Sale | Jun 12, 2026 | $304.89K |
| United Therapeutics Corp UTHR | Sale | Jun 12, 2026 | $405.46K |
| United Therapeutics Corp UTHR | Exercise | Jun 12, 2026 | $0 |